+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bilirubin Blood Test Market by Test Type, End User, Application, Product - Global Forecast 2025-2030- Product Image
Bilirubin Blood Test Market by Test Type, End User, Application, Product - Global Forecast 2025-2030- Product Image
Sale

Bilirubin Blood Test Market by Test Type, End User, Application, Product - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6013880
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bilirubin Blood Test Market grew from USD 1.09 billion in 2023 to USD 1.20 billion in 2024. It is expected to continue growing at a CAGR of 10.73%, reaching USD 2.23 billion by 2030.

The Bilirubin Blood Test, integral in diagnosing and monitoring liver conditions and newborn jaundice, has a broad application scope stretching across diagnostic centers, hospitals, and clinics. This test measures the bilirubin level in the blood, an essential indicator of liver function and blood disorders. The necessity of bilirubin testing is underscored by the increasing prevalence of liver diseases, neonatal jaundice, hemolytic anemia, and pancreas tumors, driving its essential application across medical facilities worldwide. Market insights indicate that the growing healthcare infrastructure and increased awareness regarding liver health and infant care fuel the demand for bilirubin blood tests. Technological advancements, cost-effective diagnostic procedures, and the expansion of insurance coverage are key growth influencers. Emerging markets in developing regions present potential opportunities as they strengthen healthcare systems and invest in advanced diagnostic facilities. Recommendations for market players include strategic partnerships with local health authorities and research institutions, focusing on portable and non-invasive testing models to improve access and convenience. However, limitations persist, such as the high cost of advanced testing equipment and regulatory hurdles, potentially slowing market growth. Challenges also arise from disparities in healthcare infrastructure across regions, affecting accessibility and standardization. The best innovation areas include developing automated systems for faster and more accurate results, as well as integrating AI and machine learning algorithms for predictive diagnostics and personalized medicine. Furthermore, expanding research into novel biomarkers for a broader range of liver-related conditions can provide competitive advantages. Insights into the nature of the bilirubin blood test market reveal it as highly competitive and technologically driven. Emphasizing strategic investment in R&D and participating actively in policy-making discussions can position companies to better navigate challenges and capitalize on emerging opportunities within this dynamic market landscape.

Understanding Market Dynamics in the Bilirubin Blood Test Market

The Bilirubin Blood Test Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Expansion of neonatal healthcare services increasing demand for bilirubin testing in newborns
    • Surge in point-of-care testing driving convenience and faster results for bilirubin levels
    • Higher incidence of hemolytic diseases requiring frequent bilirubin monitoring contributing to market growth
    • Government health policies and funding favoring advancements and accessibility of bilirubin testing
  • Market Restraints
    • Shortage of skilled healthcare professionals trained in bilirubin testing techniques, especially in rural areas
    • Long approval process for new bilirubin test methods and technologies by regulatory bodies
  • Market Opportunities
    • Healthcare policies supporting widespread adoption of bilirubin blood tests in rural areas
    • Rising awareness about neonatal jaundice leading to increased bilirubin testing demand
    • Partnerships between hospitals and research institutions for innovative bilirubin test solutions
  • Market Challenges
    • Supply chain disruptions affecting timely and cost-efficient distribution of bilirubin blood test kits
    • Regulatory challenges in approval processes leading to delayed introduction of innovative bilirubin testing technologies

Exploring Porter’s Five Forces for the Bilirubin Blood Test Market

Porter’s Five Forces framework further strengthens the insights of the Bilirubin Blood Test Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Bilirubin Blood Test Market

External macro-environmental factors deeply influence the performance of the Bilirubin Blood Test Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Bilirubin Blood Test Market

The Bilirubin Blood Test Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Bilirubin Blood Test Market

The Bilirubin Blood Test Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Bilirubin Blood Test Market

The Bilirubin Blood Test Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bilirubin Blood Test Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Beckman Coulter, Bio-Rad Laboratories, DiaSorin, Fujifilm Holdings Corporation, GE Healthcare, Horiba Medical, Mindray, PerkinElmer, Philips Healthcare, Quidel Corporation, Randox Laboratories, Roche Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, Tosoh Bioscience, and Trinity Biotech.

Market Segmentation & Coverage

This research report categorizes the Bilirubin Blood Test Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Test Type
    • Delta Bilirubin Test
    • Direct Bilirubin (DBIL) Test
    • Indirect Bilirubin (IBIL) Test
    • Total Serum Bilirubin (TSB) Test
      • Direct (Conjugated) Bilirubin Test
      • Indirect (Unconjugated) Bilirubin Test
  • End User
    • Ambulatory Surgical Centers (ASCs)
    • Diagnostic Laboratories
    • Home Care Settings
    • Hospitals
    • Research Institutes
  • Application
    • Bile Duct Obstruction
    • Drug-Related Toxicity
    • Hemolytic Anemia
    • Liver Diseases
    • Newborn Jaundice
  • Product
    • Instruments
    • Reagents & Kits
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expansion of neonatal healthcare services increasing demand for bilirubin testing in newborns
5.1.1.2. Surge in point-of-care testing driving convenience and faster results for bilirubin levels
5.1.1.3. Higher incidence of hemolytic diseases requiring frequent bilirubin monitoring contributing to market growth
5.1.1.4. Government health policies and funding favoring advancements and accessibility of bilirubin testing
5.1.2. Restraints
5.1.2.1. Shortage of skilled healthcare professionals trained in bilirubin testing techniques, especially in rural areas
5.1.2.2. Long approval process for new bilirubin test methods and technologies by regulatory bodies
5.1.3. Opportunities
5.1.3.1. Healthcare policies supporting widespread adoption of bilirubin blood tests in rural areas
5.1.3.2. Rising awareness about neonatal jaundice leading to increased bilirubin testing demand
5.1.3.3. Partnerships between hospitals and research institutions for innovative bilirubin test solutions
5.1.4. Challenges
5.1.4.1. Supply chain disruptions affecting timely and cost-efficient distribution of bilirubin blood test kits
5.1.4.2. Regulatory challenges in approval processes leading to delayed introduction of innovative bilirubin testing technologies
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Bilirubin Blood Test Market, by Test Type
6.1. Introduction
6.2. Delta Bilirubin Test
6.3. Direct Bilirubin (DBIL) Test
6.4. Indirect Bilirubin (IBIL) Test
6.5. Total Serum Bilirubin (TSB) Test
6.5.1. Direct (Conjugated) Bilirubin Test
6.5.2. Indirect (Unconjugated) Bilirubin Test
7. Bilirubin Blood Test Market, by End User
7.1. Introduction
7.2. Ambulatory Surgical Centers (ASCs)
7.3. Diagnostic Laboratories
7.4. Home Care Settings
7.5. Hospitals
7.6. Research Institutes
8. Bilirubin Blood Test Market, by Application
8.1. Introduction
8.2. Bile Duct Obstruction
8.3. Drug-Related Toxicity
8.4. Hemolytic Anemia
8.5. Liver Diseases
8.6. Newborn Jaundice
9. Bilirubin Blood Test Market, by Product
9.1. Introduction
9.2. Instruments
9.3. Reagents & Kits
10. Americas Bilirubin Blood Test Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Bilirubin Blood Test Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Bilirubin Blood Test Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. BILIRUBIN BLOOD TEST MARKET RESEARCH PROCESS
FIGURE 2. BILIRUBIN BLOOD TEST MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 13. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. BILIRUBIN BLOOD TEST MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. BILIRUBIN BLOOD TEST MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BILIRUBIN BLOOD TEST MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BILIRUBIN BLOOD TEST MARKET DYNAMICS
TABLE 7. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DELTA BILIRUBIN TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DIRECT BILIRUBIN (DBIL) TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY INDIRECT BILIRUBIN (IBIL) TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DIRECT (CONJUGATED) BILIRUBIN TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY INDIRECT (UNCONJUGATED) BILIRUBIN TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY BILE DUCT OBSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY DRUG-RELATED TOXICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY HEMOLYTIC ANEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY LIVER DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY NEWBORN JAUNDICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BILIRUBIN BLOOD TEST MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 48. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 53. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BILIRUBIN BLOOD TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 74. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 75. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. CHINA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 79. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 80. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. INDIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 90. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. JAPAN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 119. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 120. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. THAILAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 135. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 136. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. DENMARK BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 140. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 141. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. EGYPT BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 145. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 146. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. FINLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 150. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 151. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. FRANCE BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 156. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. GERMANY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 165. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 166. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. ITALY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 180. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 181. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. NORWAY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 185. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 186. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. POLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 190. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 191. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. QATAR BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 210. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 211. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SPAIN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 226. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. TURKEY BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY TOTAL SERUM BILIRUBIN (TSB) TEST, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM BILIRUBIN BLOOD TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 239. BILIRUBIN BLOOD TEST MARKET SHARE, BY KEY PLAYER, 2023
TABLE 240. BILIRUBIN BLOOD TEST MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Bilirubin Blood Test market, which are profiled in this report, include:
  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter
  • Bio-Rad Laboratories
  • DiaSorin
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Horiba Medical
  • Mindray
  • PerkinElmer
  • Philips Healthcare
  • Quidel Corporation
  • Randox Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific
  • Tosoh Bioscience
  • Trinity Biotech

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.2 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.23 Billion
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Bilirubin Blood Test Market Report 2024 - Product Image

Bilirubin Blood Test Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Bilirubin Blood Test Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Bilirubin Blood Test Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 112 Pages
  • Global
From
2024 North America Immunoassay Analyzers and Reagents - USA, Canada, Mexico - Supplier Shares and Competitive Analysis, 2023-2028 - Product Image

2024 North America Immunoassay Analyzers and Reagents - USA, Canada, Mexico - Supplier Shares and Competitive Analysis, 2023-2028

  • Report
  • Canada, Mexico, North America Canada, Mexico, North America
From
2024 Vietnam Immunoassay Analyzers and Reagents - Supplier Shares and Competitive Analysis, 2023-2028 - Product Image

2024 Vietnam Immunoassay Analyzers and Reagents - Supplier Shares and Competitive Analysis, 2023-2028

  • Report
  • Vietnam
From
Clinical Chemistry Analyzers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Clinical Chemistry Analyzers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 120 Pages
  • Global
From

About the Bilirubin Test Market

The Bilirubin Test is a type of In Vitro Diagnostics (IVD) used to measure the amount of bilirubin in a patient's blood. Bilirubin is a yellow pigment produced by the breakdown of red blood cells. High levels of bilirubin can indicate liver or gallbladder disease, or other conditions such as anemia. The Bilirubin Test market is composed of a variety of products, including reagents, instruments, and software. Reagents are used to measure bilirubin levels in a patient's blood, while instruments are used to analyze the results. Software is used to store and analyze the data. The Bilirubin Test market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Ortho Clinical Diagnostics, and Beckman Coulter. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.